DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Krop IE. Lin NU. Blackwell K. et al.
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.
Ann Oncol 2015;
26: 113-119
We do not assume any responsibility for the contents of the web pages of other providers.